GSK secures potential ‘multi-blockbuster’ drug in $950mn deal
Home - Financial Times [Unofficial]
February 25, 2026
New chief Luke Miels swoops on Canada’s 35Pharma in push to replenish pipeline and boost revenues
Discussion in the ATmosphere